|
HLA association
|
B
|
BB
|
BT
|
BL
|
Reaction
|
Associated phenotype
|
Population
|
Reference
|
|---|
|
A*33
|
-
|
-
|
Susc
|
-
|
-
|
Susc (L. per se)
|
Korea
|
22
|
|
B*15
|
-
|
-
|
-
|
-
|
Susc
|
-
|
-
|
-
|
|
B*58
|
-
|
Susc
|
-
|
-
|
-
|
-
|
-
|
-
|
|
B*40
|
-
|
-
|
Prot
|
-
|
-
|
-
|
-
|
-
|
|
B*49
|
Prot
|
Prot
|
Prot
|
-
|
-
|
Prot (L. per se)
|
Turkey
|
35
|
|
B*53
|
-
|
-
|
Susc
|
Susc
|
-
|
-
|
-
|
-
|
|
C*05
|
Prot
|
Prot
|
Prot
|
-
|
-
|
Prot (L. per se)
|
Brazil
|
37
|
|
C*12
|
-
|
Susc
|
-
|
-
|
-
|
Susc (L. per se)
|
Brazil
|
11
|
|
C*16
|
-
|
-
|
Susc
|
-
|
-
|
Prot (L. per se)
|
Brazil
|
11
|
|
DRB1*03
|
-
|
-
|
Susc
|
Prot
|
-
|
TT
|
Different populations
|
16,34
|
|
DRB1*07
|
Prot
|
-
|
-
|
Prot
|
-
|
Prot (MB)
|
India
|
18
|
|
DQB1*02
|
-
|
-
|
-
|
Prot
|
-
|
Prot (MB)
|
India and Argentina
|
18,38
|
|
DQB1*04
|
-
|
-
|
-
|
-
|
Susc
|
-
|
-
|
-
|
- B: borderline, BB: mid-borderline, BT: borderline tuberculoid, BL: borderline lepromatous, TT: tuberculoid leprosy; Susc: associated with susceptibility; Prot: protective association; L. per se: leprosy per se, MB: multibacillary leprosy, PB: paucibacillary leprosy; (−): no description in the literature.
